Dysphoria Induced in Dialysis Providers by Secondary Hyperparathyroidism

被引：0
|
作者：
Soomro, Irfana H. [1 ]
Goldfarb, David S. [1 ,2 ]
机构：
[1] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA
[2] New York Harbor Vet Affairs Hlth Care Syst, Nephrol Sect, New York, NY USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2015年 / 10卷 / 01期
关键词：
mineral metabolism; phosphate binders; calcium; PARATHYROID-HORMONE; HEMODIALYSIS; OUTCOMES; PTH; MORTALITY; DISEASE; ASSAY;
D O I：
10.2215/CJN.11551114
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 11
页数：3
相关论文
共 50 条
  • [31] Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes
    Mathur, Aarti
    Sutton, Whitney
    Ahn, JiYoon B.
    Prescott, Jason D.
    Zeiger, Martha A.
    Segev, Dorry L.
    McAdams-DeMarco, Mara
    TRANSPLANTATION, 2021, 105 (12) : E366 - E374
  • [32] Economic burden of secondary hyperparathyroidism in Germany: a matched comparison
    Reichel, Helmut
    Seibert, Eric
    Tillmann, Frank-Peter
    Barck, Isabella
    Grava, Astride
    Schneider, Kim Maren
    Meise, Dominic
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (05) : 1291 - 1300
  • [33] Secondary Hyperparathyroidism and Cognitive Decline
    Crepeau, Philip
    Fedorova, Tatiana
    Morris-Wiseman, Lilah F.
    Mathur, Aarti
    CURRENT TRANSPLANTATION REPORTS, 2023, 10 (02) : 60 - 68
  • [34] Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism
    Komaba, Hirotaka
    Taniguchi, Masatomo
    Wada, Atsushi
    Iseki, Kunitoshi
    Tsubakihara, Yoshiharu
    Fukagawa, Masafumi
    KIDNEY INTERNATIONAL, 2015, 88 (02) : 350 - 359
  • [35] Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis
    Cozzolino, Mario
    Bernard, Laurence
    Csomor, Philipp A.
    CLINICAL KIDNEY JOURNAL, 2021, 14 (11) : 2437 - 2443
  • [36] Optimization of calcitriol dosis in the treatment of secondary hyperparathyroidism in dialysis.: Six month results
    García, MR
    Martín, JLF
    de Castañeda, JR
    Sánchez, JH
    Andía, JBC
    NEFROLOGIA, 2002, 22 (04): : 370 - 376
  • [37] Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism
    Tsai, Wan-Chuan
    Peng, Yu-Sen
    Chiu, Yen-Ling
    Wu, Hon-Yen
    Pai, Mei-Fen
    Hsu, Shih-Ping
    Yang, Ju-Yeh
    Tung, Kuei-Ting
    Chen, Hung-Yuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (07) : 1203 - 1207
  • [38] Secondary Hyperparathyroidism
    Stack, Brendan C.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2024, 57 (01) : 99 - 110
  • [39] Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial
    Wang, Angela Yee-Moon
    Lo, Wai Kei
    Cheung, Stephen Chi-Wai
    Tang, Tak-Ka
    Yau, Yat-Yin
    Lang, Brian Hung-Hin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (08) : 1823 - 1835
  • [40] German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)
    Reichel, H.
    Braun, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (04) : 123 - 128
12345